143 related articles for article (PubMed ID: 9865620)
1. Substance P in proliferative vitreoretinopathy: the significance of aqueous humor levels for evolution of the disease.
Troger J; Kremser B; Irschick E; Göttinger W; Kieselbach G
Graefes Arch Clin Exp Ophthalmol; 1998 Dec; 236(12):900-3. PubMed ID: 9865620
[TBL] [Abstract][Full Text] [Related]
2. Elevated levels of calcitonin gene-related peptide in aqueous humor of patients with proliferative vitreoretinopathy.
Troger J; Kremser B; Stöckl T; Kralinger M; Schmid E; Kunze C; Kieselbach GF
Graefes Arch Clin Exp Ophthalmol; 2000 Mar; 238(3):237-42. PubMed ID: 10796039
[TBL] [Abstract][Full Text] [Related]
3. Postoperative aqueous humour flare as a surrogate marker for proliferative vitreoretinopathy development.
Mulder VC; van Dijk EHC; van Meurs IA; La Heij EC; van Meurs JC
Acta Ophthalmol; 2018 Mar; 96(2):192-196. PubMed ID: 29068530
[TBL] [Abstract][Full Text] [Related]
4. Different concentrations of vasoactive intestinal polypeptide in aqueous humor of patients with proliferative vitreoretinopathy and cataract patients.
Troger J; Kieselbach G; Göttinger W; Metzler R; Kähler C; Saria A
Ger J Ophthalmol; 1994 Aug; 3(4-5):245-7. PubMed ID: 7804111
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and surgical management of familial exudative vitreoretinopathy-associated rhegmatogenous retinal detachment.
Chen SN; Hwang JF; Lin CJ
Retina; 2012 Feb; 32(2):220-5. PubMed ID: 22277905
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicenter study.
Scott IU; Flynn HW; Murray TG; Feuer WJ;
Am J Ophthalmol; 2003 Sep; 136(3):454-63. PubMed ID: 12967798
[TBL] [Abstract][Full Text] [Related]
7. Levels of Anti-Retinal Antibodies in Retinal Detachment and Proliferative Vitreoretinopathy.
Ichinohasama R; Nishiguchi KM; Fujita K; Aizawa N; Inoue T; Sasaki E; Kunikata H; Nakazawa T
Curr Eye Res; 2018 Jun; 43(6):804-809. PubMed ID: 29547015
[TBL] [Abstract][Full Text] [Related]
8. Profibrotic cytokines in aqueous humour correlate with aqueous flare in patients with rhegmatogenous retinal detachment.
Hoerster R; Hermann MM; Rosentreter A; Muether PS; Kirchhof B; Fauser S
Br J Ophthalmol; 2013 Apr; 97(4):450-3. PubMed ID: 23355528
[TBL] [Abstract][Full Text] [Related]
9. Combined pars plana vitrectomy-scleral buckle versus pars plana vitrectomy for proliferative vitreoretinopathy.
Lai FH; Lo EC; Chan VC; Brelen M; Lo WL; Young AL
Int Ophthalmol; 2016 Apr; 36(2):217-24. PubMed ID: 26260357
[TBL] [Abstract][Full Text] [Related]
10. Inverse levels of pigment epithelium-derived factor and vascular endothelial growth factor in the vitreous of eyes with rhegmatogenous retinal detachment and proliferative vitreoretinopathy.
Ogata N; Nishikawa M; Nishimura T; Mitsuma Y; Matsumura M
Am J Ophthalmol; 2002 Jun; 133(6):851-2. PubMed ID: 12036691
[TBL] [Abstract][Full Text] [Related]
11. VITREORETINAL SURGERY WITH SILICONE OIL TAMPONADE IN PRIMARY UNCOMPLICATED RHEGMATOGENOUS RETINAL DETACHMENT: Clinical Outcomes and Complications.
Antoun J; Azar G; Jabbour E; Kourie HR; Slim E; Schakal A; Jalkh A
Retina; 2016 Oct; 36(10):1906-12. PubMed ID: 26966864
[TBL] [Abstract][Full Text] [Related]
12. Pars plana vitrectomy and scleral buckle versus pars plana vitrectomy alone for patients with rhegmatogenous retinal detachment at high risk for proliferative vitreoretinopathy.
Storey P; Alshareef R; Khuthaila M; London N; Leiby B; DeCroos C; Kaiser R;
Retina; 2014 Oct; 34(10):1945-51. PubMed ID: 24999720
[TBL] [Abstract][Full Text] [Related]
13. Prevention and control of proliferative vitreoretinopathy: primary retinal detachment surgery using silicone oil as a planned two-stage procedure in high-risk cases.
Alexander P; Prasad R; Ang A; Poulson AV; Scott JD; Snead MP
Eye (Lond); 2008 Jun; 22(6):815-8. PubMed ID: 17277751
[TBL] [Abstract][Full Text] [Related]
14. Clinical risk factors for proliferative vitreoretinopathy.
Cowley M; Conway BP; Campochiaro PA; Kaiser D; Gaskin H
Arch Ophthalmol; 1989 Aug; 107(8):1147-51. PubMed ID: 2757544
[TBL] [Abstract][Full Text] [Related]
15. The prognostic influence of chronicity of rhegmatogenous retinal detachment on anatomic success after reattachment surgery.
James M; O'Doherty M; Beatty S
Am J Ophthalmol; 2007 Jun; 143(6):1032-4. PubMed ID: 17524770
[TBL] [Abstract][Full Text] [Related]
16. Prediction of proliferative vitreoretinopathy after retinal detachment surgery: potential of biomarker profiling.
Ricker LJ; Kessels AG; de Jager W; Hendrikse F; Kijlstra A; la Heij EC
Am J Ophthalmol; 2012 Aug; 154(2):347-354.e2. PubMed ID: 22541653
[TBL] [Abstract][Full Text] [Related]
17. Chemokine levels in subretinal fluid obtained during scleral buckling surgery after rhegmatogenous retinal detachment.
Ricker LJ; Kijlstra A; de Jager W; Liem AT; Hendrikse F; La Heij EC
Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4143-50. PubMed ID: 20335622
[TBL] [Abstract][Full Text] [Related]
18. Primary vitrectomy versus conventional retinal detachment surgery in phakic rhegmatogenous retinal detachment.
Azad RV; Chanana B; Sharma YR; Vohra R
Acta Ophthalmol Scand; 2007 Aug; 85(5):540-5. PubMed ID: 17355251
[TBL] [Abstract][Full Text] [Related]
19. Surgical outcome of scleral buckling compared with scleral buckling with vitrectomy for treatment of macula-off retinal detachment.
Dayani PN; Blinder KJ; Shah GK; Holekamp NM; Joseph DP; Wilson B; Thomas MA; Grand MG
Ophthalmic Surg Lasers Imaging; 2009; 40(6):539-47. PubMed ID: 19928718
[TBL] [Abstract][Full Text] [Related]
20. [Vitrectomy for the treatment of retinal detachment uncomplicated by advanced proliferative vistreoretinopathy].
Li C; Gu D
Yan Ke Xue Bao; 1998 Jun; 14(2):97-9. PubMed ID: 12580042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
